Quality Assessment of Systematic Reviews of Health Economic Evaluations: Pitfalls with the Application of the PRISMA Statement. Comment on Quang et al. (Sys Rev Pharm.
Abstract
Miriam Luhnen*, Siw Waffenschmidt, Anja Schwalm, Andreas Gerber-Grote, Gloria Hanke
In a recently published article, Quang et al. evaluate the quality of system-atic reviews of health economic evaluations of interventions for hepatitis.1As the authors of one of the systematic reviews included in the assessment,2we would like to discuss the methods which were applied and which, in our opinion, seem to be inappropriate.
| How to Cite this Article |
| Pubmed Style Miriam Luhnen, Siw Waffenschmidt, Anja Schwalm, Andreas Gerber-Grote, Gloria Hanke. Quality Assessment of Systematic Reviews of Health Economic Evaluations: Pitfalls with the Application of the PRISMA Statement. Comment on Quang et al. (Sys Rev Pharm. 2017;8(1):52-61). SRP. 2018; 9(1): 83-84. doi:10.5530/srp.2018.1.16 Web Style Miriam Luhnen, Siw Waffenschmidt, Anja Schwalm, Andreas Gerber-Grote, Gloria Hanke. Quality Assessment of Systematic Reviews of Health Economic Evaluations: Pitfalls with the Application of the PRISMA Statement. Comment on Quang et al. (Sys Rev Pharm. 2017;8(1):52-61). http://www.sysrevpharm.org/?mno=302644554 [Access: March 28, 2021]. doi:10.5530/srp.2018.1.16 AMA (American Medical Association) Style Miriam Luhnen, Siw Waffenschmidt, Anja Schwalm, Andreas Gerber-Grote, Gloria Hanke. Quality Assessment of Systematic Reviews of Health Economic Evaluations: Pitfalls with the Application of the PRISMA Statement. Comment on Quang et al. (Sys Rev Pharm. 2017;8(1):52-61). SRP. 2018; 9(1): 83-84. doi:10.5530/srp.2018.1.16 Vancouver/ICMJE Style Miriam Luhnen, Siw Waffenschmidt, Anja Schwalm, Andreas Gerber-Grote, Gloria Hanke. Quality Assessment of Systematic Reviews of Health Economic Evaluations: Pitfalls with the Application of the PRISMA Statement. Comment on Quang et al. (Sys Rev Pharm. 2017;8(1):52-61). SRP. (2018), [cited March 28, 2021]; 9(1): 83-84. doi:10.5530/srp.2018.1.16 Harvard Style Miriam Luhnen, Siw Waffenschmidt, Anja Schwalm, Andreas Gerber-Grote, Gloria Hanke (2018) Quality Assessment of Systematic Reviews of Health Economic Evaluations: Pitfalls with the Application of the PRISMA Statement. Comment on Quang et al. (Sys Rev Pharm. 2017;8(1):52-61). SRP, 9 (1), 83-84. doi:10.5530/srp.2018.1.16 Turabian Style Miriam Luhnen, Siw Waffenschmidt, Anja Schwalm, Andreas Gerber-Grote, Gloria Hanke. 2018. Quality Assessment of Systematic Reviews of Health Economic Evaluations: Pitfalls with the Application of the PRISMA Statement. Comment on Quang et al. (Sys Rev Pharm. 2017;8(1):52-61). Systematic Reviews in Pharmacy, 9 (1), 83-84. doi:10.5530/srp.2018.1.16 Chicago Style Miriam Luhnen, Siw Waffenschmidt, Anja Schwalm, Andreas Gerber-Grote, Gloria Hanke. "Quality Assessment of Systematic Reviews of Health Economic Evaluations: Pitfalls with the Application of the PRISMA Statement. Comment on Quang et al. (Sys Rev Pharm. 2017;8(1):52-61)." Systematic Reviews in Pharmacy 9 (2018), 83-84. doi:10.5530/srp.2018.1.16 MLA (The Modern Language Association) Style Miriam Luhnen, Siw Waffenschmidt, Anja Schwalm, Andreas Gerber-Grote, Gloria Hanke. "Quality Assessment of Systematic Reviews of Health Economic Evaluations: Pitfalls with the Application of the PRISMA Statement. Comment on Quang et al. (Sys Rev Pharm. 2017;8(1):52-61)." Systematic Reviews in Pharmacy 9.1 (2018), 83-84. Print. doi:10.5530/srp.2018.1.16 APA (American Psychological Association) Style Miriam Luhnen, Siw Waffenschmidt, Anja Schwalm, Andreas Gerber-Grote, Gloria Hanke (2018) Quality Assessment of Systematic Reviews of Health Economic Evaluations: Pitfalls with the Application of the PRISMA Statement. Comment on Quang et al. (Sys Rev Pharm. 2017;8(1):52-61). Systematic Reviews in Pharmacy, 9 (1), 83-84. doi:10.5530/srp.2018.1.16 |
Abstract
PDF
How to cite this article
Related Records